September 2022
Michael Story, Ph.D., and Narasimha Karanam, Ph.D., awarded Novocure grant
Michael Story, Ph.D., and Narasimha Karanam, Ph.D., were awarded a Novocure grant for their research, "An evidence-based approach to enhancing the response of tumors to radiation, Tumor Treating Fields, and targeted agents." Their award spans July 1, 2022 - June 30, 2025.
March 2022
Michael Story, Ph.D., spoke at the Worldwide Federation of Neuro-Oncology Societies Meeting
Dr. Story spoke at the Worldwide Federation of Neuro-Oncology Societies meeting in Seoul, Korea. His talk was entitled “Disruptive technology: the mechanism(s) of action of Tumor Treating Fields exposure."
March 2022
Michael Story, Ph.D., spoke at the Society for Brain Mapping and Therapeutics Annual Meeting
Dr. Story spoke at the Society for Brain Mapping and Therapeutics Annual Meeting in Los Angeles. His talk was entitled "The tumoricidal mechanisms of action for Tumor Treating Fields."
Society for Brain Mapping and Therapeutics Annual MeetingMay 2021
Dr. Story's research: an experimental drug makes radiation therapy more effective, less damaging
Dr. Story's research on an experimental drug that makes radiation therapy more effective and less damaging receives national attention.
Read the press releaseMarch 2021
Drs. Story, Saha, and Karanam granted a patent for developing a novel method of killing cancer cells
Drs. Michael Story, Debabrata Saha, and Narasimha Kumar Karanam were granted a patent for developing a novel method of killing cancer cells that combines a PARP inhibitor, such as Olaparib, with Tumor Treating Fields, which are low intensity, intermediate frequency electric fields, applied to tumors. This method is based on preclinical findings that showed synergistic cancer cell killing when Tumor Treating Fields were used in combination with a PARP inhibitor.
Learn more about this methodNovember 2020
2020 SNO Virtual Meeting
Drs. Karanam and Story's presentation entitled "Therapeutic implications of conditional vulnerabilities caused by TTFields exposure in novel combination therapies for non-small cell lung cancer and brain metastases from non-small cell lung cancer" was selected for on-demand oral presentation at this year's SNO Annual Meeting.
November 2020
AACR-Novocure grantees’ collaboration plants the seeds for future therapeutics
Narasimha Kumar Karanam, Ph.D., received an AACR-Novocure Career Development Award for Tumor Treating Fields Research.
Learn more about this awardOctober 2020
2020 ASTRO Virtual Meeting
Drs. Karanam and Story presented a poster entitled "Tumor Treating Fields Disrupt the CDK-E2F-Rb Axis: Implications for the Use of Radiation and Targeted Agents Against E2F and CDK4/6 During TTFields Treatment" at the 2020 ASTRO virtual meeting.
2020 ASTRO virtual meetingOctober 2020
Published review in International Journal of Radiation Biology
"An Overview of Potential Novel Mechanisms of Action Underlying Tumor Treating Fields-Induced Cancer Cell Death and Their Clinical Implications," written by Drs. Karanam and Story, was published in the International Journal of Radiation Biology.
Read the full published review
June 2020
Brock Sishc, Ph.D., hired by NASA's Johnson Space Center
Brock Sishc, Ph.D., part of UTSW since 2014, has been recruited by NASA's Johnson Space Center to serve as the cancer discipline lead within the Space Radiation Element, a part of the Human Research Program. Brock's primary role will be to support the chief and deputy element scientists in the direction and development of research goals including gaining an understanding of the risk of space radiation exposure to astronaut health.
Human Research Program
April 2020
Narasimha Kumar Karanam, Ph.D., receives AACR-Novocure Career Development award from AACR
Narasimha Kumar Karanam, Ph.D., recently received AACR-Novocure Career Development Award from American Association for Cancer Research (AACR) which awards him a three-year grant of $225,000 to study system level effects through trans-omics approach and to find novel combination therapies together with Tumor Treating Fields.
AACR-Novocure Career Development AwardApril 2020
Brock Sishc, Ph.D., awarded $30K augmentation to Story Lab NASA grant
Brock Sishc was awarded a $30K augmentation to the Story Lab's NASA grant. He will study the role of estrogen in space radiation-induced lung cancer risk in female mice.
April 2020
Michael Story, Ph.D., elected to the Board of Directors of the National Council on Radiation Protection and Measurements
Dr. Michael Story was elected to the Board of Directors of the National Council on Radiation Protection and Measurements (NCRP).
National Council on Radiation Protection and Measurements (NCRP)April 2019
Michael Story, Ph.D., awarded 2019 AACR-Novocure research grant
Dr. Story was awarded an AACR-Novocure Tumor Treating Fields research grant for his work "Exploiting the conditional vulnerabilities caused by TTFields exposure" at the American Association for Cancer Research (AACR) Annual Meeting 2019 in Atlanta.
Read more about this award